INTREPID POTASH INC (IPI) Stock Fundamental Analysis
NYSE:IPI - New York Stock Exchange, Inc. - US46121Y2019 - Common Stock - Currency: USD
Taking everything into account, IPI scores 3 out of 10 in our fundamental rating. IPI was compared to 85 industry peers in the Chemicals industry. While IPI has a great health rating, there are worries on its profitability. IPI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
IPI had positive earnings in the past year.
IPI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IPI reported negative net income in multiple years.
In the past 5 years IPI always reported a positive cash flow from operatings.
1.2 Ratios
IPI has a Return On Assets of -34.11%. This is amonst the worse of the industry: IPI underperforms 88.24% of its industry peers.
Looking at the Return On Equity, with a value of -42.78%, IPI is doing worse than 81.18% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.13%, IPI is doing worse than 77.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.11% | ||
| ROE | -42.78% | ||
| ROIC | 0.13% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IPI has a worse Operating Margin (0.35%) than 77.65% of its industry peers.
The Gross Margin of IPI (13.64%) is worse than 76.47% of its industry peers.
In the last couple of years the Gross Margin of IPI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 13.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
2. Health
2.1 Basic Checks
IPI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IPI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IPI has less shares outstanding
The debt/assets ratio for IPI has been reduced compared to a year ago.
2.2 Solvency
IPI has an Altman-Z score of 2.79. This is not the best score and indicates that IPI is in the grey zone with still only limited risk for bankruptcy at the moment.
IPI has a better Altman-Z score (2.79) than 75.29% of its industry peers.
The Debt to FCF ratio of IPI is 0.25, which is an excellent value as it means it would take IPI, only 0.25 years of fcf income to pay off all of its debts.
IPI has a Debt to FCF ratio of 0.25. This is amongst the best in the industry. IPI outperforms 97.65% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that IPI is not too dependend on debt financing.
The Debt to Equity ratio of IPI (0.00) is better than 96.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.25 | ||
| Altman-Z | 2.79 |
ROIC/WACC0.02
WACC8.96%
2.3 Liquidity
A Current Ratio of 5.17 indicates that IPI has no problem at all paying its short term obligations.
IPI has a Current ratio of 5.17. This is amongst the best in the industry. IPI outperforms 92.94% of its industry peers.
IPI has a Quick Ratio of 2.62. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
IPI's Quick ratio of 2.62 is amongst the best of the industry. IPI outperforms 87.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.17 | ||
| Quick Ratio | 2.62 |
3. Growth
3.1 Past
IPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.67%, which is quite impressive.
Looking at the last year, IPI shows a small growth in Revenue. The Revenue has grown by 0.63% in the last year.
IPI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.96% yearly.
EPS 1Y (TTM)110.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%378.57%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%23.3%
3.2 Future
IPI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.26% yearly.
Based on estimates for the next years, IPI will show a decrease in Revenue. The Revenue will decrease by -0.21% on average per year.
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue Next Year3.33%
Revenue Next 2Y-0.31%
Revenue Next 3Y-0.21%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 457.75, IPI can be considered very expensive at the moment.
IPI's Price/Earnings ratio is a bit more expensive when compared to the industry. IPI is more expensive than 68.24% of the companies in the same industry.
IPI is valuated expensively when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for IPI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 457.75 | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as IPI.
IPI's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.51 | ||
| EV/EBITDA | 11.12 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IPI's earnings are expected to decrease with -4.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)2.32
PEG (5Y)N/A
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
5. Dividend
5.1 Amount
IPI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
36.62
+0.51 (+1.41%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners56.04%
Inst Owner Change4.05%
Ins Owners1.99%
Ins Owner Change-0.71%
Market Cap487.78M
Analysts42.22
Price Target21.42 (-41.51%)
Short Float %3.39%
Short Ratio1.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)365.13%
Min EPS beat(2)-142.02%
Max EPS beat(2)872.28%
EPS beat(4)1
Avg EPS beat(4)-141.12%
Min EPS beat(4)-1288.12%
Max EPS beat(4)872.28%
EPS beat(8)1
Avg EPS beat(8)-133.02%
EPS beat(12)1
Avg EPS beat(12)-97.98%
EPS beat(16)3
Avg EPS beat(16)-73.69%
Revenue beat(2)2
Avg Revenue beat(2)13.58%
Min Revenue beat(2)9.74%
Max Revenue beat(2)17.42%
Revenue beat(4)4
Avg Revenue beat(4)19.17%
Min Revenue beat(4)9.74%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)23.01%
Revenue beat(12)11
Avg Revenue beat(12)19.62%
Revenue beat(16)15
Avg Revenue beat(16)18.77%
PT rev (1m)10.53%
PT rev (3m)5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)625%
EPS NY rev (1m)0%
EPS NY rev (3m)825%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 457.75 | ||
| Fwd PE | N/A | ||
| P/S | 1.79 | ||
| P/FCF | 76.51 | ||
| P/OCF | 11.65 | ||
| P/B | 1.02 | ||
| P/tB | 1.07 | ||
| EV/EBITDA | 11.12 |
EPS(TTM)0.08
EY0.22%
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)0.48
FCFY1.31%
OCF(TTM)3.14
OCFY8.59%
SpS20.51
BVpS35.99
TBVpS34.2
PEG (NY)2.32
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.11% | ||
| ROE | -42.78% | ||
| ROCE | 0.17% | ||
| ROIC | 0.13% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.15% | ||
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 13.64% | ||
| FCFM | 2.33% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score5
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.25 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 91.35% | ||
| Cap/Sales | 13% | ||
| Interest Coverage | 2.22 | ||
| Cash Conversion | 105.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.17 | ||
| Quick Ratio | 2.62 | ||
| Altman-Z | 2.79 |
F-Score5
WACC8.96%
ROIC/WACC0.02
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%378.57%
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue 1Y (TTM)0.63%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%23.3%
Revenue Next Year3.33%
Revenue Next 2Y-0.31%
Revenue Next 3Y-0.21%
Revenue Next 5YN/A
EBIT growth 1Y111.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1489.26%
EBIT Next 3Y128.42%
EBIT Next 5YN/A
FCF growth 1Y132.2%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y-33.63%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%